Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

January/February 2021

Letting the Pandemic Propel Us Forward
Letting the Pandemic Propel Us Forward
02/22/2021
Winston Wong, PharmD
It is now 2021—a new year where we have an opportunity to move forward with a fresh perspective. As we continue to contend with the ongoing COVID-19 pandemic, we have been reminded that we are a resilient and...
It is now 2021—a new year where we have an opportunity to move forward with a fresh perspective. As we continue to contend with the ongoing COVID-19 pandemic, we have been reminded that we are a resilient and...
It is...
02/22/2021
Journal of Clinical Pathways
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
02/22/2021
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...
Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...
Health...
02/22/2021
Journal of Clinical Pathways
Positive Disruption in the COVID-19 Era: AMCCBS Virtual
02/22/2021
Association of Community Cancer Centers
The past year challenged cancer care professionals in ways that were seemingly unimaginable. With the spread of SARS-CoV-2 across the United States, cancer programs and practices were forced to dramatically change...
The past year challenged cancer care professionals in ways that were seemingly unimaginable. With the spread of SARS-CoV-2 across the United States, cancer programs and practices were forced to dramatically change...
The...
02/22/2021
Journal of Clinical Pathways
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
02/22/2021
Jason Shafrin, PhD
Marlon Graf, PhD
Rifat Tuly, MPH
Christoph Glaetzer, Dipl Kfm
Stacey Hickson, PhD
T Joseph Mattingly II, PhD, PharmD, MBA
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
...
02/22/2021
Journal of Clinical Pathways
Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer
Research Report
Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer
02/22/2021
Karen A Sereday, MS
David C Boulware, MS
Sandra C Stewart, CTR
Yaroslav Shtogun, PhD
Dung-Tsa Chen, PhD
Ashley A Durand, MS
Peter AS Johnstone, MD
Julio M Pow-Sang, MD
Tracy C Simpson
Dana E Rollison, PhD
Karen K Fields, MD
Abstract: We analyzed adherence to multidisciplinary clinical pathways to understand the impact on the cost of care for patients with prostate cancer. Methods: A retrospective cohort design identified 560 patients...
Abstract: We analyzed adherence to multidisciplinary clinical pathways to understand the impact on the cost of care for patients with prostate cancer. Methods: A retrospective cohort design identified 560 patients...
...
02/22/2021
Journal of Clinical Pathways

Column

COA Viewpoint
Meeting the Challenges of Community Oncology at the Virtual #COA2021
02/22/2021
Fred Divers, MD
While the rollercoaster ride of 2020 is now over, the repercussions from events over those months will persist into 2021, creating new challenges for community oncology. How will practices adapt to the influx of new...
While the rollercoaster ride of 2020 is now over, the repercussions from events over those months will persist into 2021, creating new challenges for community oncology. How will practices adapt to the influx of new...
While...
02/22/2021
Journal of Clinical Pathways

Department

Research in Review
Research in Review
02/22/2021
JCP Editors
Reviewing the latest research on value-based care, clinical pathways, and precision medicine Patient-Provider Discussions About Cancer Treatment Costs Decrease Out-of-Pocket Spending Patient-provider discussions...
Reviewing the latest research on value-based care, clinical pathways, and precision medicine Patient-Provider Discussions About Cancer Treatment Costs Decrease Out-of-Pocket Spending Patient-provider discussions...
...
02/22/2021
Journal of Clinical Pathways

Feature

Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer
Research Report
Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer
02/22/2021
Karen A Sereday, MS
David C Boulware, MS
Sandra C Stewart, CTR
Yaroslav Shtogun, PhD
Dung-Tsa Chen, PhD
Ashley A Durand, MS
Peter AS Johnstone, MD
Julio M Pow-Sang, MD
Tracy C Simpson
Dana E Rollison, PhD
Karen K Fields, MD
Abstract: We analyzed adherence to multidisciplinary clinical pathways to understand the impact on the cost of care for patients with prostate cancer. Methods: A retrospective cohort design identified 560 patients...
Abstract: We analyzed adherence to multidisciplinary clinical pathways to understand the impact on the cost of care for patients with prostate cancer. Methods: A retrospective cohort design identified 560 patients...
...
02/22/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Volume 7

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement